Journal of Clinical Endocrinology & Metabolism, Vol 66, 343-348, Copyright © 1988 by Endocrine Society

ARTICLES

Salivary cortisol measurement: a practical approach to assess pituitary- adrenal function

MH Laudat, S Cerdas, C Fournier, D Guiban, B Guilhaume and JP Luton
Laboratoire d'Hormonologie, Hopital Cochin, Paris, France.

The salivary cortisol concentration is an excellent indicator of the plasma free cortisol concentration. To establish its normal and pathological ranges, salivary cortisol concentrations were measured in 101 normal adults, 18 patients with Cushing's syndrome, and 21 patients with adrenal insufficiency. The normal subjects had a mean (+/- SEM) salivary cortisol concentration of 15.5 +/- 0.8 nmol/L (range, 10.2- 27.3) at 0800 h and 3.9 +/- 0.2 nmol/L (range, 2.2-4.1) at 2000 h (n = 20). The mean value 60 min after ACTH administration in 58 normal subjects was 52.2 +/- 2.2 nmol/L (range, 23.5-99.4), and it was 1.4 +/- 1.1 nmol/L (range, 1.6-3) at 0800 h in 23 normal subjects given 1 mg dexamethasone 8 h earlier. In patients with primary or secondary adrenal insufficiency (n = 21) the mean salivary cortisol level was 7.5 +/- 0.4 nmol/L (range, 1.9-21.8) 60 min after ACTH. In patients with Cushing's syndrome (n = 7), the mean value after the 1-mg dexamethasone suppression test was 16.1 +/- 7.8 nmol/L (range, 5.8-66.8). No overlap was found between the values in the normal subjects and those in the patients during the dynamic tests. Discrepancies between salivary and total plasma cortisol were found in 8 patients with adrenal insufficiency, which may be explained by the effects of drugs such as thyroid hormones, Op'-dichlorodiphenyldichloroethane, and psychotropic agents. We conclude that salivary cortisol measurements are an excellent index of plasma free cortisol concentrations. They circumvent the physiological, pathological, and pharmacological changes due to corticosteroid-binding globulin alterations and offer a practical approach to assess pituitary-adrenal function.

This article has been cited by other articles:

				L. K. Nieman, B. M. K. Biller, J. W. Findling, J. Newell-Price, M. O. Savage, P. M. Stewart, and V. M. Montori The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1526 - 1540. [Abstract] [Full Text] [PDF]

				S. Kidambi, H. Raff, and J. W Findling Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome Eur. J. Endocrinol., December 1, 2007; 157(6): 725 - 731. [Abstract] [Full Text] [PDF]

				B. M. Arafah, F. J. Nishiyama, H. Tlaygeh, and R. Hejal Measurement of Salivary Cortisol Concentration in the Assessment of Adrenal Function in Critically Ill Subjects: A Surrogate Marker of the Circulating Free Cortisol J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2965 - 2971. [Abstract] [Full Text] [PDF]

				M. Christ-Crain, S. Jutla, I. Widmer, O. Couppis, C. Konig, H. Pargger, J. Puder, R. Edwards, B. Muller, and A. B. Grossman Measurement of Serum Free Cortisol Shows Discordant Responsivity to Stress and Dynamic Evaluation J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1729 - 1735. [Abstract] [Full Text] [PDF]

				J. W. Findling and H. Raff Cushing's Syndrome: Important Issues in Diagnosis and Management J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3746 - 3753. [Abstract] [Full Text] [PDF]

				B. M. Arafah Hypothalamic Pituitary Adrenal Function during Critical Illness: Limitations of Current Assessment Methods J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3725 - 3745. [Abstract] [Full Text] [PDF]

				R. S. Chriguer, L. L. K. Elias, I. M. da Silva Jr., J. G. H. Vieira, A. C. Moreira, and M. de Castro Glucocorticoid Sensitivity in Young Healthy Individuals: in Vitro and in Vivo Studies J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5978 - 5984. [Abstract] [Full Text] [PDF]

				M. Yaneva, H. Mosnier-Pudar, M.-A. Dugue, S. Grabar, Y. Fulla, and X. Bertagna Midnight Salivary Cortisol for the Initial Diagnosis of Cushing's Syndrome of Various Causes J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3345 - 3351. [Abstract] [Full Text] [PDF]

				H. Raff and J. W. Findling A Physiologic Approach to Diagnosis of the Cushing Syndrome Ann Intern Med, June 17, 2003; 138(12): 980 - 991. [Full Text] [PDF]

				M. Duclos, C. Gouarne, and D. Bonnemaison Acute and chronic effects of exercise on tissue sensitivity to glucocorticoids J Appl Physiol, March 1, 2003; 94(3): 869 - 875. [Abstract] [Full Text] [PDF]

				D. A. Papanicolaou, N. Mullen, I. Kyrou, and L. K. Nieman Nighttime Salivary Cortisol: A Useful Test for the Diagnosis of Cushing's Syndrome J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4515 - 4521. [Abstract] [Full Text] [PDF]

				P. Bergmann, S. Huber, H. Machler, E. Liebl, H. Hinghofer-Szalkay, P. Rehak, and B. Rigler The Influence of Medical Information on the Perioperative Course of Stress in Cardiac Surgery Patients Anesth. Analg., November 1, 2001; 93(5): 1093 - 1099. [Abstract] [Full Text] [PDF]

				A. Chouker, M. Thiel, V. Baranov, D. Meshkov, A. Kotov, K. Peter, K. Messmer, and F. Christ Simulated microgravity, psychic stress, and immune cells in men: observations during 120-day 6{degrees} HDT J Appl Physiol, May 1, 2001; 90(5): 1736 - 1743. [Abstract] [Full Text] [PDF]

				G. Lac, P. Marquet, A. P. Chassain, and F. X. Galen Dexamethasone in resting and exercising men. II. Effects on adrenocortical hormones J Appl Physiol, July 1, 1999; 87(1): 183 - 188. [Abstract] [Full Text] [PDF]

				M. Castro, P. C. L. Elias, A. R. P. Quidute, F. P. B. Halah, and A. C. Moreira Out-Patient Screening for Cushing's Syndrome: The Sensitivity of the Combination of Circadian Rhythm and Overnight Dexamethasone Suppression Salivary Cortisol Tests J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 878 - 882. [Abstract] [Full Text]

				H. Raff, J. L. Raff, and J. W. Findling Late-Night Salivary Cortisol as a Screening Test for Cushing's Syndrome J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2681 - 2686. [Abstract] [Full Text]

				G. Arnaldi, J.-M. Gasc, Y. de Keyzer, M.-L. Raffin-Sanson, V. Perraudin, J.-M. Kuhn, M.-C. Raux-Demay, J.-P. Luton, E. Clauser, and X. Bertagna Variable Expression of the V1 Vasopressin Receptor Modulates the Phenotypic Response of Steroid-Secreting Adrenocortical Tumors J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2029 - 2035. [Abstract] [Full Text]

				K. Tamate, M. Charleton, J. P. Gosling, D. Egan, M. Ishikawa, P. F. Fottrell, and M. M. Kane Direct colorimetric monoclonal antibody enzyme immunoassay for estradiol-17{beta} in saliva Clin. Chem., July 1, 1997; 43(7): 1159 - 1164. [Abstract] [Full Text] [PDF]